Evidence map›Paper›PMID 34577852›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.

Yutaka Yamada, Hisao Imai, Tomohide Sugiyama, Hiroyuki Minemura, Kenya Kanazawa, Takashi Kasai, Koichi Minato, Kyoichi Kaira, Takayuki Kaburagi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yutaka YamadaDepartment of Respiratory Medicine, Ibaraki Prefectural Central Hospital, Kasama 309-1793, Ibaraki, Japan.ORCID 0000-0001-6823-4231
Hisao ImaiDepartment of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama University Hospital, Hidaka 350-1298, Saitama, Japan.ORCID 0000-0003-3097-4255
Tomohide SugiyamaDivision of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya 320-0834, Tochigi, Japan.
Hiroyuki MinemuraDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.ORCID 0000-0001-8710-1960
Kenya KanazawaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
Takashi KasaiDivision of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya 320-0834, Tochigi, Japan.
Koichi MinatoDivision of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota 373-8550, Gunma, Japan.
Kyoichi KairaDepartment of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama University Hospital, Hidaka 350-1298, Saitama, Japan.ORCID 0000-0001-5548-7686
Takayuki KaburagiDepartment of Respiratory Medicine, Ibaraki Prefectural Central Hospital, Kasama 309-1793, Ibaraki, Japan.
Fukushima Medical University · JPIbaraki Prefectural Central Hospital · JPSaitama University · JPTochigi Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsPharmaceutical PreparationsAgedAged, 80 and overErbB ReceptorsHumansMutationProtein Kinase InhibitorsRetrospective StudiesEGFR protein, humanErbB ReceptorsPharmaceutical PreparationsProtein Kinase Inhibitorsadvanced non-small-cell lung cancerEGFR mutationsEGFR-TKIelderly patientsepidermal growth factor receptorre-administrationsecondary chemotherapytyrosine kinase inhibitor

Identifiers

PMID34577852
PMCPMC8466413
OpenAlexW3198727144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.